Market Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
66.73 +0.34  +0.50% NYSE Arca Jan 26, 1:28PM BATS Real time Currency in USD
View Full Chart
PPH Price Chart

PPH Description

Market Vectors Pharmaceutical ETF is a long only equity fund managed by Market Vectors that tracks the MV US Listed Pharmaceutical 25 NR USD index and has 344.98M USD assets under management. It has an expected distribution yield of 1.64%, a Forecasted PE Ratio of 20.42, and a Forecasted Price to Book Value of 3.754. The fund has a net expense ratio of 0.35%, turns over its positions 14.00% per year, and is traded on the New York Stock Exchange Arca.

PPH Key Info

Expense Ratio (9-30-14) 0.35%
Assets Under Management (1-16-15) 344.98M
30-Day Average Volume (1-23-15) 109644.6
Net Asset Value (1-23-15) 66.37
Discount or Premium to NAV (1-16-15) 0.05%
Turnover Ratio (9-30-14) 14.00%

PPH Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 100.2% 100.2% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.15% 0.00% 0.15%
As of Jan. 15, 2015

PPH Region Exposure

Americas 59.17%
North America 59.17%
Latin America 0.00%
Greater Europe 40.83%
United Kingdom 12.98%
Europe Developed 23.84%
Europe Emerging 0.00%
Africa/Middle East 4.01%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Jan. 22, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Jan. 15, 2015

PPH Stock Market Capitalization

Giant 79.50%
Large 17.86%
Medium 2.79%
Small 0.00%
Micro 0.00%
As of Jan. 15, 2015
View More Holdings

PPH Top 10 Holdings

Name % Weight Price Chg %
Novartis AG ADR 9.65% 96.48 -0.40%
Johnson & Johnson 8.89% 102.01 -0.19%
Pfizer Inc 6.70% 32.74 +0.89%
Merck & Co Inc 5.13% 62.84 +0.56%
GlaxoSmithKline PLC ADR 4.90% 45.31 +0.67%
Sanofi ADR 4.88% 46.85 -0.06%
Novo Nordisk A/S ADR 4.79% 45.27 +3.17%
Bristol-Myers Squibb Company 4.65% 62.53 +0.74%
AbbVie Inc 4.62% 62.66 +0.37%
Allergan Inc 4.59% 226.97 +1.25%
As of Jan. 15, 2015
Get Quote for
Advertisement

PPH Basic Info

Style
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name Market Vectors
Benchmark Index
MV US Listed Pharmaceutical 25 NR USD 100.0%
Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2014
Last Prospectus Date 2/1/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

PPH Manager Info

Name Tenure
George Cao 3.03 yrs
Hao-Hung (Peter) Liao 3.03 yrs

PPH Risk Info

Beta --
30 Day Average Volatility 16.06%

PPH Fundamentals

Dividend Yield TTM (1-26-15) 1.64%
Weighted Average PE Ratio 25.87
Weighted Average Price to Sales Ratio 2.766
Weighted Average Price to Book Ratio 3.996
Weighted Median ROE 22.30%
Weighted Median ROA 8.44%
Forecasted Dividend Yield 2.14%
Forecasted PE Ratio 20.42
Forecasted Price to Sales Ratio 2.894
Forecasted Price to Book Ratio 3.754
Number of Holdings 25.00
As of Jan. 15, 2015

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 7.94%
Forecasted Book Value Growth 6.45%
Forecasted Cash Flow Growth -1.67%
Forecasted Earnings Growth -1.07%
Forecasted Revenue Growth 3.10%
As of Jan. 15, 2015

PPH Performance

  Returns Total Returns
1M 3.57% 3.96%
3M 8.43% 8.84%
6M 7.44% 8.18%
1Y 21.24% 23.42%
3Y 82.17% 96.01%
5Y -- --
As of Jan. 23, 2015

PPH Flows

1M -25.98M
3M -86.59M
6M -41.03M
YTD -3.768M
1Y -3.768M
3Y -60.39M
5Y --
As of Dec. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.